The Role of Radiomics in Rectal Cancer

Nenhuma Miniatura disponível
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
MIRANDA, Joao
HORVAT, Natally
ARAUJO-FILHO, Jose A. B.
ALBUQUERQUE, Kamila S. S.
CHARBEL, Charlotte
CARDOSO, Daniel L. L.
CHAKRABORTY, Jayasree
Citação
JOURNAL OF GASTROINTESTINAL CANCER, v.54, n.4, p.1158-1180, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
PurposeRadiomics is a promising method for advancing imaging assessment in rectal cancer. This review aims to describe the emerging role of radiomics in the imaging assessment of rectal cancer, including various applications of radiomics based on CT, MRI, or PET/CT.MethodsWe conducted a literature review to highlight the progress of radiomic research to date and the challenges that need to be addressed before radiomics can be implemented clinically.ResultsThe results suggest that radiomics has the potential to provide valuable information for clinical decision-making in rectal cancer. However, there are still challenges in terms of standardization of imaging protocols, feature extraction, and validation of radiomic models. Despite these challenges, radiomics holds great promise for personalized medicine in rectal cancer, with the potential to improve diagnosis, prognosis, and treatment planning. Further research is needed to validate the clinical utility of radiomics and to establish its role in routine clinical practice.ConclusionOverall, radiomics has emerged as a powerful tool for improving the imaging assessment of rectal cancer, and its potential benefits should not be underestimated.
Palavras-chave
Rectal cancer, Radiomics, Texture analysis, Magnetic resonance imaging, Computed tomography, Positron emission tomography
Referências
  1. Aker M, 2019, DIS COLON RECTUM, V62, P163, DOI 10.1097/DCR.0000000000001224
  2. American Cancer Society, 2022, KEY STAT COL CANC
  3. Babcock BD, 2018, ANN SURG ONCOL, V25, P1980, DOI 10.1245/s10434-018-6484-8
  4. Bera K, 2022, NAT REV CLIN ONCOL, V19, P132, DOI 10.1038/s41571-021-00560-7
  5. Bibault JE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30657-6
  6. Bodalal Z, 2019, ABDOM RADIOL, V44, P1960, DOI 10.1007/s00261-019-02028-w
  7. Bulens P, 2020, RADIOTHER ONCOL, V142, P246, DOI 10.1016/j.radonc.2019.07.033
  8. Chen FY, 2021, ACAD RADIOL, V28, pS87, DOI 10.1016/j.acra.2020.09.024
  9. Chen HH, 2020, ADV RADIAT ONCOL, V5, P1286, DOI 10.1016/j.adro.2020.04.016
  10. Chen JY, 2021, ABDOM RADIOL, V46, P847, DOI 10.1007/s00261-020-02710-4
  11. Chen YD, 2022, ABDOM RADIOL, V47, P1276, DOI 10.1007/s00261-021-03397-x
  12. Chuanji Z, 2022, TRANSL ONCOL, V18, DOI 10.1016/j.tranon.2022.101352
  13. Cui Y, 2018, EUR RADIOL
  14. Cui YF, 2020, EUR RADIOL, V30, P1948, DOI 10.1007/s00330-019-06572-3
  15. Cui YF, 2019, J MAGN RESON IMAGING, V50, P930, DOI 10.1002/jmri.26653
  16. Cusumano D, 2017, RADIOL MED
  17. Dinapoli N, 2018, INT J RADIAT ONCOL, V102, P765, DOI 10.1016/j.ijrobp.2018.04.065
  18. Duldulao MP, 2013, DIS COLON RECTUM, V56, P142, DOI 10.1097/DCR.0b013e31827541e2
  19. Ejaz A, 2017, J SURG RES, V215, P12, DOI 10.1016/j.jss.2017.03.017
  20. Fan SX, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.644933
  21. Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169
  22. GLOBOCAN, 2022, WHO INT AG RES CANC
  23. Guo XF, 2020, CURR MED SCI, V40, P1156, DOI 10.1007/s11596-020-2298-6
  24. Guo Y, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88831-2
  25. Habr-Gama A, 2004, ANN SURG, V240, P711, DOI 10.1097/01.sla.0000141194.27992.32
  26. Horvat N, 2018, RADIOLOGY
  27. Horvat N, 2022, ABDOM RADIOL, V47, P2972, DOI 10.1007/s00261-021-03359-3
  28. Horvat N, 2019, EUR J RADIOL, V113, P174, DOI 10.1016/j.ejrad.2019.02.022
  29. Hu PP, 2016, ONCOTARGET, V7, P71440, DOI 10.18632/oncotarget.12199
  30. Huang ZX, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019428
  31. Jang BS, 2021, ANTICANCER RES, V41, P3969, DOI 10.21873/anticanres.15193
  32. Jeon SH, 2020, IN VIVO, V34, P2955, DOI 10.21873/invivo.12126
  33. Jeon SH, 2019, RADIAT ONCOL, V14, DOI 10.1186/s13014-019-1246-8
  34. Lambin P, 2017, NAT REV CLIN ONCOL, V14, P749, DOI 10.1038/nrclinonc.2017.141
  35. Li M, 2021, WORLD J GASTROENTERO, V27, P5610, DOI 10.3748/wjg.v27.i33.5610
  36. Li M, 2020, WORLD J GASTROENTERO, V26, DOI 10.3748/wjg.v26.i33.5008
  37. Li YQ, 2019, CANCER MED-US, V8, P7244, DOI 10.1002/cam4.2636
  38. Li ZY, 2020, WORLD J GASTROENTERO, V26, P2388, DOI 10.3748/wjg.v26.i19.2388
  39. Li ZH, 2021, BMC MED IMAGING, V21, DOI 10.1186/s12880-021-00560-0
  40. Li ZB, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.697497
  41. Linsalata S, 2022, BIOMED RES INT-UK, V2022, DOI 10.1155/2022/2003286
  42. Liu SY, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.610338
  43. Liu XC, 2021, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.585767
  44. Liu ZY, 2017, CLIN CANCER RES, V23, P7253, DOI 10.1158/1078-0432.CCR-17-1038
  45. Lovinfosse P, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20160212
  46. Lu HD, 2021, BIOMED RES INT-UK, V2021, DOI 10.1155/2021/5566885
  47. Lubner MG, 2017, RADIOGRAPHICS, V37, P1483, DOI 10.1148/rg.2017170056
  48. Maas M, 2015, ANN SURG ONCOL, V22, P3873, DOI 10.1245/s10434-015-4687-9
  49. Meng X, 2018, EUR RADIOL
  50. Meng Y, 2018, J MAGN RESON IMAGING
  51. Meng Y., 2018, ONCOTARGET, V9, P11999, DOI 10.18632/oncotarget.23813
  52. Miranda J, 2022, CLIN IMAG, V82, P141, DOI 10.1016/j.clinimag.2021.10.005
  53. Morin O, 2018, INT J RADIAT ONCOL, V102, P1074, DOI 10.1016/j.ijrobp.2018.08.032
  54. Nie K, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.779030
  55. Nie K, 2016, CLIN CANCER RES, V22, P5256, DOI 10.1158/1078-0432.CCR-15-2997
  56. Nougaret S, 2016, RADIOLOGY, V280, P446, DOI 10.1148/radiol.2016150702
  57. Nozawa H, 2018, IN VIVO, V32, P1235, DOI 10.21873/invivo.11370
  58. Oh JE, 2020, CANCER RES TREAT, V52, P51, DOI 10.4143/crt.2019.050
  59. Palmisano A, 2020, CLIN RADIOL, V75, DOI 10.1016/j.crad.2020.06.023
  60. Pei C, 2020, J MAGN RESON IMAGING, V52, P161, DOI 10.1002/jmri.27029
  61. Petkovska I, 2020, ABDOM RADIOL, V45, P3608, DOI 10.1007/s00261-020-02502-w
  62. Petresc B, 2020, CANCERS, V12, DOI 10.3390/cancers12071894
  63. Rai R, 2022, J MED IMAGING, V9, DOI 10.1117/1.JMI.9.4.044005
  64. Rizzo Stefania, 2018, Eur Radiol Exp, V2, P36, DOI 10.1186/s41747-018-0068-z
  65. Röhrich S, 2020, RADIOL-CARDIOTHORAC, V2, DOI 10.1148/ryct.2020190190
  66. Rutman AM, 2009, EUR J RADIOL, V70, P232, DOI 10.1016/j.ejrad.2009.01.050
  67. Schurink NW, 2021, EUR RADIOL
  68. Shahzadi I, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-13967-8
  69. Shaish H, 2020, EUR RADIOL, V30, P6263, DOI 10.1007/s00330-020-06968-6
  70. Shayesteh SP, 2019, PHYS MEDICA, V62, P111, DOI 10.1016/j.ejmp.2019.03.013
  71. Shu ZY, 2022, EUR RADIOL, V32, P1002, DOI 10.1007/s00330-021-08242-9
  72. Shur JD, 2021, RADIOGRAPHICS, V41, P1717, DOI 10.1148/rg.2021210037
  73. Song GS, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.945559
  74. Song LR, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01364
  75. Su Y, 2022, J NEUROL, V269, P6386, DOI 10.1007/s00415-022-11258-w
  76. Tibermacine H, 2021, BRIT J SURG, V108, P1243, DOI 10.1093/bjs/znab191
  77. Traverso A, 2019, PHYS MEDICA, V61, P44, DOI 10.1016/j.ejmp.2019.04.009
  78. Van Cutsem E, 2015, J CLIN ONCOL, V33, P692, DOI 10.1200/JCO.2014.59.4812
  79. van Griethuysen JJM, 2020, ABDOM RADIOL, V45, P632, DOI 10.1007/s00261-019-02321-8
  80. Wagner MW, 2021, NEURORADIOLOGY, V63, P1957, DOI 10.1007/s00234-021-02813-9
  81. Wang DQ, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.846840
  82. Wang FQ, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-10175-2
  83. Wang J, 2021, ABDOM RADIOL, V46, P1805, DOI 10.1007/s00261-020-02846-3
  84. Wu YQ, 2022, BMC MED IMAGING, V22, DOI 10.1186/s12880-022-00813-6
  85. Xu YY, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6341-6
  86. Xu YY, 2018, EUR RADIOL, V28, P3059, DOI 10.1007/s00330-018-5329-y
  87. Yang C, 2020, INT J COLORECTAL DIS, V35, P101, DOI 10.1007/s00384-019-03455-3
  88. Yang YS, 2021, CANCER IMAGING, V21, DOI 10.1186/s40644-021-00408-4
  89. Yang YS, 2021, ABDOM RADIOL, V46, P873, DOI 10.1007/s00261-020-02733-x
  90. Yeo DM, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3724393
  91. Yi XP, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00552
  92. Yu XL, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00459
  93. Yuan H, 2022, CANCER MANAG RES, V14, P2409, DOI 10.2147/CMAR.S377138
  94. Yuan Y, 2022, ABDOM RADIOL, V47, P1741, DOI 10.1007/s00261-022-03477-6
  95. Yuan ZG, 2020, J MED IMAG RADIAT ON, V64, P444, DOI 10.1111/1754-9485.13044
  96. Zhang W, 2021, ANN TRANSL MED, V9, DOI 10.21037/atm-20-7673
  97. Zhang Y, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.828904
  98. Zhang YC, 2022, WORLD J GASTROENTERO, V28, P3960, DOI 10.3748/wjg.v28.i29.3960
  99. Zhao L, 2021, ABDOM RADIOL, V46, P3815, DOI 10.1007/s00261-021-03021-y
  100. Zhou XZ, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00604
  101. Zhou XZ, 2019, ANN SURG ONCOL, V26, P1676, DOI 10.1245/s10434-019-07300-3
  102. Zhu HT, 2019, CHINESE J CANCER RES, V31, P984, DOI 10.21147/j.issn.1000-9604.2019.06.14